Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.

Thakur SB, Brennan SB, Ishill NM, Morris EA, Liberman L, Dershaw DD, Bartella L, Koutcher JA, Huang W.

J Magn Reson Imaging. 2011 Apr;33(4):855-63. doi: 10.1002/jmri.22493.

PMID:
21448950
2.

Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.

Lipnick S, Liu X, Sayre J, Bassett LW, Debruhl N, Thomas MA.

NMR Biomed. 2010 Oct;23(8):922-30. doi: 10.1002/nbm.1511.

PMID:
20878970
3.

Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy.

Kvistad KA, Bakken IJ, Gribbestad IS, Ehrnholm B, Lundgren S, Fjøsne HE, Haraldseth O.

J Magn Reson Imaging. 1999 Aug;10(2):159-64.

PMID:
10441019
4.

Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.

Qi ZH, Li CF, Li ZF, Zhang K, Wang Q, Yu DX.

Chin Med J (Engl). 2009 Jan 5;122(1):39-43.

PMID:
19187615
6.

Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.

Dorrius MD, Pijnappel RM, Jansen-van der Weide MC, Jansen L, Kappert P, Oudkerk M, Sijens PE.

Radiology. 2011 Jun;259(3):695-703. doi: 10.1148/radiol.11101855. Epub 2011 Apr 1.

PMID:
21460033
7.

In vivo proton magnetic resonance spectroscopy of breast lesions: an update.

Tse GM, Yeung DK, King AD, Cheung HS, Yang WT.

Breast Cancer Res Treat. 2007 Sep;104(3):249-55. Epub 2006 Oct 19. Review.

PMID:
17051424
8.

Clinical utility of proton magnetic resonance spectroscopy in characterizing breast lesions.

Katz-Brull R, Lavin PT, Lenkinski RE.

J Natl Cancer Inst. 2002 Aug 21;94(16):1197-203. Review.

PMID:
12189222
9.

(1)H MR spectroscopy with external reference solution at 1.5 T for differentiating malignant and benign breast lesions: comparison using qualitative and quantitative approaches.

Mizukoshi W, Kozawa E, Inoue K, Saito N, Nishi N, Saeki T, Kimura F.

Eur Radiol. 2013 Jan;23(1):75-83. doi: 10.1007/s00330-012-2555-6. Epub 2012 Jul 10.

PMID:
22777619
10.

Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.

Hsieh TJ, Li CW, Chuang HY, Liu GC, Wang CK.

J Comput Assist Tomogr. 2008 Nov-Dec;32(6):987-94. doi: 10.1097/RCT.0b013e31815b9ce9.

PMID:
19204465
11.

In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.

Sardanelli F, Fausto A, Di Leo G, de Nijs R, Vorbuchner M, Podo F.

AJR Am J Roentgenol. 2009 Jun;192(6):1608-17. doi: 10.2214/AJR.07.3521.

PMID:
19457825
12.

Quantitative multivoxel proton chemical shift imaging of the breast.

Sijens PE, Dorrius MD, Kappert P, Baron P, Pijnappel RM, Oudkerk M.

Magn Reson Imaging. 2010 Apr;28(3):314-9. doi: 10.1016/j.mri.2009.11.004. Epub 2010 Jan 13.

PMID:
20071119
13.

Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?

Baltzer PA, Gussew A, Dietzel M, Rzanny R, Gajda M, Camara O, Reichenbach JR, Kaiser WA.

NMR Biomed. 2012 Jan;25(1):67-74. doi: 10.1002/nbm.1714. Epub 2011 May 9.

PMID:
21557368
14.

Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T.

Stanwell P, Gluch L, Clark D, Tomanek B, Baker L, Giuffrè B, Lean C, Malycha P, Mountford C.

Eur Radiol. 2005 May;15(5):1037-43. Epub 2004 Sep 3.

PMID:
15351906
15.
16.

In vivo 1H-MRS evaluation of malignant and benign breast diseases.

Kim JK, Park SH, Lee HM, Lee YH, Sung NK, Chung DS, Kim OD.

Breast. 2003 Jun;12(3):179-82.

PMID:
14659324
17.

Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.

Jagannathan NR, Kumar M, Seenu V, Coshic O, Dwivedi SN, Julka PK, Srivastava A, Rath GK.

Br J Cancer. 2001 Apr 20;84(8):1016-22.

18.

[In vivo proton MR spectroscopy of normal liver parenchyma: technique and results].

Müller C, Hübner F, Bisdas S, Herzog C, Hammerstingl RM, Ackermann H, Vorbuchner M, Vogl TJ.

Rofo. 2006 Nov;178(11):1128-36. German.

PMID:
17128381
19.

Single voxel in vivo proton magnetic resonance spectroscopy of breast lesions: experience in 77 cases.

Başara I, Örgüç Ş, Coşkun T.

Diagn Interv Radiol. 2013 May-Jun;19(3):221-6. doi: 10.5152/dir.2012.005.

20.

Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.

Server A, Josefsen R, Kulle B, Maehlen J, Schellhorn T, Gadmar Ø, Kumar T, Haakonsen M, Langberg CW, Nakstad PH.

Acta Radiol. 2010 Apr;51(3):316-25. doi: 10.3109/02841850903482901.

PMID:
20092374

Supplemental Content

Support Center